Evidence map›Paper›PMID 29905792›Full record

ReviewFEMS yeast research2018

Yeast as a tool to identify anti-aging compounds.

Andreas Zimmermann, Sebastian Hofer, Tobias Pendl, Katharina Kainz, Frank Madeo, Didac Carmona-Gutierrez

Open access · hybridAbstract readReview
In one paragraph

Review in FEMS yeast research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 129 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The geroprotective potential of chalcones.Nature communications · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Glucosinolates from Seed-Press Cake ofAntioxidants (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Effect of Dihydroquercetin During Long-Last Growth ofInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Arctigenin fromAntioxidants (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. International journal of molecular sciences · 2023
    Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Andreas ZimmermannInstitute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, 8010, Austria.
Sebastian HoferInstitute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, 8010, Austria.
Tobias PendlInstitute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, 8010, Austria.
Katharina KainzInstitute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, 8010, Austria.
Frank MadeoInstitute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, 8010, Austria.
Didac Carmona-GutierrezInstitute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, 8010, Austria.
University of Graz · ATNawi Graz · ATBioTechMed-Graz · AT

Funding

Austrian Science Fund FWF W 1226
6 · The paper itself

Abstract

In the search for interventions against aging and age-related diseases, biological screening platforms are indispensable tools to identify anti-aging compounds among large substance libraries. The budding yeast, Saccharomyces cerevisiae, has emerged as a powerful chemical and genetic screening platform, as it combines a rapid workflow with experimental amenability and the availability of a wide range of genetic mutant libraries. Given the amount of conserved genes and aging mechanisms between yeast and human, testing candidate anti-aging substances in yeast gene-deletion or overexpression collections, or de novo derived mutants, has proven highly successful in finding potential molecular targets. Yeast-based studies, for example, have led to the discovery of the polyphenol resveratrol and the natural polyamine spermidine as potential anti-aging agents. Here, we present strategies for pharmacological anti-aging screens in yeast, discuss common pitfalls and summarize studies that have used yeast for drug discovery and target identification.

Indexed as

Drug DiscoveryModels, BiologicalAgingGene LibraryGenetic TestingHumansMicrobial ViabilityPhenotypeSaccharomyces cerevisiaeSmall Molecule LibrariesSmall Molecule Libraries

Identifiers

PMID29905792
PMCPMC6001894
OpenAlexW2794166136

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.